Despite these promising data, very little literature regarding anti-VEGF therapy on MCC is available: Tarabadkar described five cases of successful use of anti-VEGF TKIs such as pazopanib and CBZ in patients with advanced MCC [52]. Here, VEGFA is linked to Merkel cell skin cancer.